Dünya Sağlık Örgütü’nün Araştırma-Geliştirme Stratejik Planı: Salgınlara Hızlı Yanıt İçin Bir Yol Haritası

Öz

Dünya Sağlık Örgütü'nün Araştırma-Geliştirme Stratejik Planının temel amacı, gelecekte meydana gelebilecek salgınlara bilimsel ve teknolojik açıdan daha hazırlıklı olmayı sağlamaktır. Bu kapsamda öncelikli patojenlerin belirlenmesi, aşı ve tedavi geliştirme süreçlerinin hızlandırılması ve küresel iş birliğinin artırılması hedeflenmiştir. 2018 yılı sonunda bulaşıcı hastalıklar için nihai öncelikli 10 hastalık listesini yayımlamıştır, metodolojiler değiştikçe bu listeyi güncellemekte ve hastalıkların her biri için Araştırma-Geliştirme yol haritaları geliştirmeye çalışmaktadır. COVID-19 pandemisi, Blueprint yaklaşımının etkinliğini görünür hale getirmiş; küresel ölçekte tanı, tedavi ve aşı geliştirme süreçlerinde planın sağladığı bilimsel iş birliği ve yönlendirme kapasitesi somut biçimde gözlemlenmiştir. Küresel sağlık sistemlerinin dayanıklılığını artırmak, finansal ve bilimsel kaynakların adil dağılımını sağlamak ve sürdürülebilir Araştırma-Geliştirme kapasitesi oluşturmak, Dünya Sağlık Örgütü'nün Araştırma-Geliştirme Stratejik Planının uzun vadeli başarısı için temel öncelikler arasında yer almalıdır. Bu derlemede Dünya Sağlık Örgütü’nün salgınlara hızlı yanıt için geliştirdiği Araştırma-Geliştirme Stratejik Planı’nın ve plan dahilindeki hastalıkların incelenmesi amaçlanmıştır.

Anahtar Kelimeler

• dünya sağlık örgütü
• araştırma ve geliştirme
• pandemik
• salgınlar

Destekleyen Kurum

Yazarlar, herhangi bir dış finansman veya destek almadıklarını beyan ederler.

Etik Beyan

Yazarlar herhangi bir çıkar çatışması beyan etmemektedir.

The World Health Organization Research&Development Blueprint: A Roadmap for Rapid Response to Epidemics

Öz

The primary objective of the World Health Organization’s Research and Development (R&D) Strategic Plan is to ensure scientific and technological preparedness for potential future outbreaks. Within this framework, the identification of priority pathogens, the acceleration of vaccine and therapeutic development processes, and the strengthening of global collaboration have been set as key goals. At the end of 2018, it published the final list of the top 10 priority infectious diseases, updates this list as methodologies evolve, and seeks to develop research and development roadmaps for each of these diseases. The COVID-19 pandemic made the effectiveness of the Blueprint approach clearly visible; the scientific collaboration and strategic guidance capacity provided by the plan were concretely demonstrated at the global level through accelerated processes for the development of diagnostics, therapeutics, and vaccines. Enhancing the resilience of global health systems, ensuring the equitable distribution of financial and scientific resources, and establishing sustainable R&D capacity should remain among the core priorities for the long-term success of the World Health Organization’s R&D Strategic Plan. This review aims to examine the World Health Organization’s R&D Strategic Plan developed for rapid outbreak response and the diseases included within the scope of the plan.

Anahtar Kelimeler

• world health organization
• research and development
• pandemics
• outbreaks

Destekleyen Kurum

The authors declare that they received no external funding or support.

Etik Beyan

The authors declare no conflict of interest.

Kaynakça

1. Allen T, Murray KA, Zambrana-Torrelio C, et al. Global hotspots and correlates of emerging zoonotic diseases. Nat Commun. 2017;8:1124.
2. Wu T. The socioeconomic and environmental drivers of the COVID-19 pandemic: A review. Ambio. 2021;50(4):822-33.
3. Pitt SJ, Gunn A. The One Health Concept. Br J Biomed Sci. 2004;81:12366.
4. Kieny MP, Røttingen JA. Research and development (R&D) preparedness for infectious disease epidemics. Bull World Health Organ. 2016;94(9):593.
5. World Health Organization. An R&D Blueprint for action to prevent epidemics. Geneva: WHO; 2016. Available from: https://www.who.int/blueprint/en/. Accessed May 27, 2026.
6. World Health Organization. R&D Blueprint for Epidemics. Available from: https://www.who.int/teams/blueprint/who-r-and-d-blueprint-for-epidemics. Accessed May 28, 2026.
7. Kyobe Bosa H, Kamara N, Aragaw M, et al. The west Africa Ebola virus disease outbreak: 10 years on. Lancet Glob Health. 2024;12(7):e1081-3.
8. Moon S, Sridhar D, Pate M, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The Lancet. 2015;386(10009):2204–21.

9. Gostin LO, Friedman EA. Ebola: A crisis in global health leadership. The Lancet. 2014;384(9951):1323–25.
10. Fauci AS. Research priorities in the response to the 2014–2016 Ebola outbreak. N Engl J Med. 2017;377:874–6.
11. Mehand MS, Al-Shorbaji F, Millett P, Murgue B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral research. 2018;159:63.
12. Mehand MS, Millett P, Al-Shorbaji F, Roth C, Kieny MP, Murgue B. World Health Organization Methodology to prioritize emerging infectious diseases in need of research and development. Emerg Infect Dis. 2018;24(9):e171427.
13. World Health Organization. Disease Outbreak News. Multi-country monkeypox outbreak: Situation update (4 June 2022). Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON390 Accessed May 27, 2026.
14. World Health Organization. WHO R&D Blueprint: Global coordination mechanism for R&D preparedness and response. Geneva: World Health Organization; 2024. Available from: https://www.who.int/teams/blueprint. Accessed May 28, 2026.
15. World Health Organization. R&D Blueprint – Research and Development for Epidemic Preparedness Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/who-blueprint-prioritization-2022. Accessed May 28, 2026.
16. Herson J. Clinical trial preparations for the next pandemic. Contemp Clin Trials. 2021;102:106292.
17. Saxena A, Horby P, Amuasi J, et al. Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel. BMC Med Ethics. 2019;20(1):29.
18. Coalition for Epidemic Preparedness Innovations (CEPI). Our work and partnerships. Oslo: CEPI; 2024. Available from: https://cepi.net/our-work/. Accessed May 27, 2026.
19. GAVI, The Vaccine Alliance. COVAX and global vaccine equity initiatives. Geneva: GAVI; 2024. Available from: https://www.gavi.org/. Accessed May 28, 2026.
20. National Institutes of Health (NIH). Global health research and emerging pathogens. Bethesda (MD): NIH; 2023. Available from: https://www.nih.gov/research-training Accessed May 28, 2026.
21. Thelwall M, Simrick S, VineyI, et al. What is research funding, how does it influence research, and how is it recorded? Key dimensions of variation. Scientometrics 2023;128:6085–106.
22. World Health Organization. Ethical standards for research during public health emergencies. Geneva: WHO Research Ethics Review Committee (ERC); 2023. Available from: https://www.who.int/groups/research-ethics-review-committee. Accessed May 27, 2026.
23. World Health Organization. A coordinated global research roadmap. 2019 Novel Coronavirus. 12 March 2020. Available from: https://www.who.int/publications/m/item/a-coordinated-global-research-roadmap. Accessed May 27, 2026.
24. World Health Organization. WHO R&D Blueprint. Mapping of R&D stakeholders. Available from: https://www.who.int/observatories/global-observatory-on-health-research-and-development/analyses-and-syntheses/who-r-d-blueprint/who-mapping-of-r-d-stakeholders. Accessed May 27, 2026.
25. FAO, UNEP, WHO, and WOAH. One Health Joint Plan of Action (2022-2026). Working together for the health of humans, animals, plants and the environment. Rome;2022. Available from: https://iris.who.int/server/api/core/bitstreams/578db93c-0ada-4c37-bcb5-e1dff68f4a0d/content. Accessed May 28, 2026.
26. Pate MA, Bali S. 28 Financing Emergency Research Response During Infectious Disease Outbreaks: Lessons from the World Bank and Other International Financial Institutions. In: Sorenson, R.A. (eds) Principles and Practice of Emergency Research Response. Springer, Cham.; 2024.
27. Modjarrad K, Moorthy VS, Millett P, Gsell PS, Roth C, Kieny MP. Developing global norms for sharing data and results during public health emergencies. PLoS Med. 2016;13(1):e1001935.
28. World Health Organization. Data sharing in public health emergencies: A guidance for policy makers. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/data-sharing-guidance. Accessed May 27, 2026.
29. World Health Organization. Research Ethics Review Committee (ERC).Available from: https://www.who.int/groups/research-ethics-review-committee/guidance-for-submissions-of-documents. Accessed May 27, 2026.
30. Jonkmans N, D’Acremont V, Flahault A. Scoping future outbreaks: A scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases. BMJ Global Health 2021;6(9):e006623.
31. Yadav PD, Baid K, Patil DY, et al. A One Health approach to understanding and managing Nipah virus outbreaks. Nat Microbiol. 2025;10(6):1272-81.
32. World Health Organization. Prioritizing diseases for research and development in emergency contexts. Available from:https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts?utm_source=pocket_saves. Accessed May 27, 2026.
33. Bardhan M, Ray I, Roy S, et al. Disease X and COVID-19: Turning lessons from India and the world into policy recommendations. Ann Med Surg (Lond). 2024;86(10):5914-21.
34. World Health Organization. COVID-19 Research and Innovation Achievements. COVID-19 Global Research & Innovation Forum. 13&14 May 2021. Available from:https://www.who.int/teams/blueprint/covid-19/covid-19-global-research-innovation-forum. Accessed May 27, 2026.
35. World Health Organization Access to COVID-19 Tools (ACT) Accelerator. 2020. Available from:https://www.who.int/initiatives/act-accelerator. Accessed May 27, 2026.